RTI Surgical (NSDQ:RTIX) said it’s launching a new line of spinal implants, the Streamline OCT system, for fusion procedures involving the occipto-cervico-thoracic spine.

Alachua, Fla.-based RTI said it won 510(k) clearance from the FDA for the Streamline OCT devices, for the treatment of conditions including spinal stenosis, tumors, degenerative disc disease and spondylolisthesis.

The device is designed to provide spinal fusion from the occiput at the base of the skull to the T-3 vertebra in the thorax, according to a press release.

"The Streamline OCT system is another exciting addition to our spine portfolio," president & CEO Brian Hutchison said in prepared remarks. "We are proud to have a system that offers a range of implants where surgeons can tailor treatment for their patients and provide a more streamlined surgical experience."

"The Streamline OCT system, with its unsurpassed modularity, ensures I can manage the variety of clinical challenges I come across in my practice," added Dr. Anthony Lapinsky, of Premier Orthopaedics & Sports Medicine, who is 1 of the design surgeons for this system. "This is due, in large part, to a number of unique implant options, including the highest angle screw on the market."

In February, RTI extended a supply deal between its Pioneer Surgical Technology business and Zimmer (NYSE:ZMH).